Abstract
Myocardial tissue engineering involves the design of biomaterial scaffolds, aiming at regenerating necrotic myocardium after myocardial infarction. Biomaterials provide mechanical support to the infarct area and they can be used as vehicles for sustained and controlled local administration of cells and growth factors. Although promising results have been reported in experimental studies, many issues need to be addressed before human use.
Keywords: Biomaterial scaffold, cardiac repair, heart failure, myocardial infarction, ventricular remodeling, tissue engineering, necrotic, Hypertrophy, Infarct Healing, Gelatin, Nano-Clays, Alginate
Mini-Reviews in Medicinal Chemistry
Title: Tissue Engineering for Post-Myocardial Infarction Ventricular Remodeling
Volume: 11 Issue: 3
Author(s): T. M. Kolettis, A. Vilaeti, K. Dimos, N. Tsitou and S. Agathopoulos
Affiliation:
Keywords: Biomaterial scaffold, cardiac repair, heart failure, myocardial infarction, ventricular remodeling, tissue engineering, necrotic, Hypertrophy, Infarct Healing, Gelatin, Nano-Clays, Alginate
Abstract: Myocardial tissue engineering involves the design of biomaterial scaffolds, aiming at regenerating necrotic myocardium after myocardial infarction. Biomaterials provide mechanical support to the infarct area and they can be used as vehicles for sustained and controlled local administration of cells and growth factors. Although promising results have been reported in experimental studies, many issues need to be addressed before human use.
Export Options
About this article
Cite this article as:
M. Kolettis T., Vilaeti A., Dimos K., Tsitou N. and Agathopoulos S., Tissue Engineering for Post-Myocardial Infarction Ventricular Remodeling, Mini-Reviews in Medicinal Chemistry 2011; 11 (3) . https://dx.doi.org/10.2174/138955711795049853
DOI https://dx.doi.org/10.2174/138955711795049853 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dynamic Ventricular Repolarisation: From Physiology to Prognosis
Current Cardiology Reviews Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology Modulators of Inhibitor of Growth (ING) Family Expression in Development and Disease
Current Drug Targets The Prostaglandin Agonist Beraprost Aggravates Doxorubicin-mediated Apoptosis by Increasing iNOS Expression in Cardiomyocytes
Current Vascular Pharmacology Molecular Modeling Investigation of Some New 2-mercaptoimidazoles
Current Computer-Aided Drug Design Humoral Immunity in Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Meet Our Editorial Board Member
Current Drug Targets Aldose Reductase: A Novel Target for Cardioprotective Interventions
Current Drug Targets Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders
Current Pharmaceutical Design Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends
Current Pharmaceutical Design Perspective on the Role of Four Beta-blockers in Heart Failure
Current Reviews in Clinical and Experimental Pharmacology Editorial: Cocaine and Cerebral Small Vessel: Is it a Negative Factor for Intravenous Thrombolysis?
Current Vascular Pharmacology Editorial [Hot Topic: Pathogenesis and Treatment of Diabetic Complications,Retinopathy, Nephropathy and Cardiomyopathy (Executive Editor: J.L. Wilkinson-Berka)]
Current Pharmaceutical Design Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Current Pharmaceutical Design Alzheimer Disease and Diabetes Mellitus: Do They have Anything in Common?
Current Alzheimer Research Immunopathological Aspects of Mycoplasma pneumoniae Infection
Current Pediatric Reviews Cell Biological Consequences of Mitochondrial NADH: Ubiquinone Oxidoreductase Deficiency
Current Neurovascular Research Relaxin Receptors - New Drug Targets for Multiple Disease States
Current Drug Targets Phenotyping and Genotyping of the Ryanodine Receptor-Associated Genetic Diseases Using Peripheral Lymphocytes
Current Pharmacogenomics Heat Shock Protein-60 and Risk for Cardiovascular Disease
Current Pharmaceutical Design